fluorodeoxyglucose f18 has been researched along with Waldenstrom Macroglobulinemia in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 4 (40.00) | 2.80 |
Authors | Studies |
---|---|
Cao, X; Li, F; Li, J; Luo, Y; Pan, Q | 2 |
Chen, G; Chen, X; Fu, Z; Li, Q | 1 |
Arulogun, S; Bomanji, J; Priftakis, D; Riaz, S; Wan, S | 1 |
Delmer, A; Dupuis, J; Durot, E; Godet, S; Hivert, B; Ivanoff, S; Kanagaratnam, L; Le Dû, K; Leblond, V; Lemal, R; Leprêtre, S; Merabet, F; Michallet, AS; Morel, P; Perrot, A; Regny, C; Roussel, X; Sutton, L; Tomowiak, C; Toussaint, E; Van Den Neste, E; Zini, JM | 1 |
Cao, X; Feng, J; Li, F; Luo, Y; Pan, Q | 1 |
Flynt, L; Illarramendi, OA; Wong, F | 1 |
Ding, CY; Guo, Z; Li, TN; Liu, HY | 1 |
Bagshaw, M; Banwait, R; Campigotto, F; Ghobrial, IM; Harris, B; Leduc, R; Leleu, X; O'Regan, K; Ramaiya, N; Weller, E; Yarar, D | 1 |
Barlogie, B; Dhodapkar, M; Eidelberg, D; Harik, SI; Rudnicki, SA | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Waldenstrom Macroglobulinemia
Article | Year |
---|---|
The role of 18F-FDG PET/CT imaging in Waldenstrom macroglobulinemia.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Pyrazines; Radiography; Radiopharmaceuticals; Rituximab; Waldenstrom Macroglobulinemia | 2011 |
9 other study(ies) available for fluorodeoxyglucose f18 and Waldenstrom Macroglobulinemia
Article | Year |
---|---|
Baseline 18 F-FDG PET/CT May Portend the Prognosis of Patients With Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma After First-Line Treatment.
Topics: Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden; Waldenstrom Macroglobulinemia | 2022 |
18 F-FDG PET/CT Findings in Waldenström Macroglobulinemia With Mesentery Involvement.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Mesentery; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Waldenstrom Macroglobulinemia | 2023 |
Before and After Treatment Characterization of Cerebrospinal Disease in Bing-Neel Syndrome Using 18F FDG PET/MRI.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Nervous System Diseases; Positron-Emission Tomography; Waldenstrom Macroglobulinemia | 2020 |
Chemokine Receptor 4-Targeted 68Ga-Pentixafor PET/CT in Response Assessment of Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: Comparison to 18F-FDG PET/CT.
Topics: Coordination Complexes; Fluorodeoxyglucose F18; Humans; Lymphoma; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Prospective Studies; Receptors, CXCR4; Waldenstrom Macroglobulinemia | 2021 |
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Cell Transformation, Neoplastic; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Rituximab; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Waldenstrom Macroglobulinemia | 2017 |
Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenström Macroglobulinemia.
Topics: Aged; Coordination Complexes; Female; Fluorodeoxyglucose F18; Humans; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Waldenstrom Macroglobulinemia | 2018 |
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Pain; Positron Emission Tomography Computed Tomography; Waldenstrom Macroglobulinemia | 2019 |
[PET-CT Manifestation and Clinical Analysis of Waldenstrom Macroglobulinemia].
Topics: Fluorodeoxyglucose F18; Humans; Immunoglobulin M; Middle Aged; Platelet Count; Positron Emission Tomography Computed Tomography; Retrospective Studies; Waldenstrom Macroglobulinemia | 2016 |
Nervous system dysfunction in Waldenström's macroglobulinemia: response to treatment.
Topics: Antibodies, Monoclonal; Bone Marrow Transplantation; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunoglobulin M; Male; Middle Aged; Myelin-Associated Glycoprotein; Neural Conduction; Parkinson Disease, Secondary; Peripheral Nervous System Diseases; Tomography, Emission-Computed; Waldenstrom Macroglobulinemia | 1998 |